Blarcamesine matches Leqembi's efficacy and outperforms donepezil, with a better safety profile and easier oral administration. Leqembi poses serious side effects, especially in APOE4 carriers, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback